Alcatel-Lucent Company Profile

06:07 EST 23rd November 2017 | BioPortfolio

Alcatel-Lucent (Euronext Paris and NYSE: ALU) is the trusted partner of service providers, enterprises and governments worldwide, providing solutions to deliver voice, data and video communication services to end-users. A leader in fixed, mobile and converged broadband networking, IP technologies, applications and services, Alcatel-Lucent leverages the unrivalled technical and scientific expertise of Bell Labs, one of the largest innovation powerhouses in the communications industry. With operations in more than 130 countries and the most experienced global services organization in the industry, Alcatel-Lucent is a local partner with a global reach. Alcatel-Lucent achieved revenues of Euro 16.98 billion in 2008 and is incorporated in France, with executive offices located in Paris. For more information, visit Alcatel-Lucent on the Internet:

News Articles [5 Associated News Articles listed on BioPortfolio]

Novartis, Bayer push back on talk of off-label use of Avastin in UK

Physicians in northern England say off-label use of Roche's cancer drug Avastin instead of Bayer's Eylea or Novartis's Lucent -More- 

VMDOC® Appoints Kia Mousavi as New CEO

VMDOC® a leading SMART Patient Care Management Platform provider, announced today that it has appointed serial entrepreneur, Kia Mousavi, as chief executive office and a member o...

Global Cordless Phone Market Research 2011 2022 [Report Updated: 22062017] Prices from USD $2210

SummaryCordless phone is a model of telephone which replaces the coiled wire between the handset and base unit with wireless radio technology. A cordless phone is not the same as a wireless phone, how...

Global Solar Encapsulation Materials Market Research 2011 2022 [Report Updated: 27062017] Prices from USD $2170

SummarySolar encapsulation materials are encapsulant sheets that protect the solar cell to ensure its performance and reliability. Solar encapsulation materials should be stable at elevated temperatur...

Iris Plans Raises $5.1 Million to Expand Tech and Video-Based Advance Care Planning Nationally

Company will use funds to enhance its technology platform, hire key staff and expand national partnerships with healthcare providers and payers. Iris Plans, Inc. (www.i...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Shiseido white lucent brightening spot-control foundation (refill) [SHISEIDO AMERICA INC.]

SHISEIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill)

Shiseido white lucent [SHISEIDO AMERICA INC.]

SHISEIDO WHITE LUCENT Brightening Spot-Control Base UV

Shiseido white lucent [SHISEIDO AMERICA INC.]


Shiseido white lucent [SHISEIDO AMERICA INC.]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Ultrastructural characteristics of ovine bone marrow-derived mesenchymal stromal cells cultured with a silicon stabilized tricalcium phosphate bioceramic.

Bioceramics are being used in experimental bone engineering application in association with bone marrow derived mesenchymal stem cells (BM-MSCs) as a new therapeutic tool, but their effects on the ult...

Lower-Extremity Pseudomyogenic Hemangioendothelioma on Bone Scintigraphy and PET/CT.

An otherwise healthy 33-year-old man presents with new pain involving the right leg. Radiographs of the femur showed scattered lucent lesions. An MRI of the knee demonstrated nonspecific cortical-base...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Synthetic Aperture Radar Detection of Breast Tumours

The study will seek to understand the effective use of a novel Microwave Radar Breast Imaging System in a Symptomatic Breast Care Clinic. The MARIA Imaging system uses low level non--ionis...

A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty

SUMMARY A prospective, randomized, single-blinded clinical trial is proposed to compare three tibial tray designs for patients undergoing total knee arthroplasty. This study is designed to...

Companies [12 Associated Companies listed on BioPortfolio]


Alcatel-Lucent (Euronext Paris and NYSE: ALU) is the trusted partner of service providers, enterprises and governments worldwide, providing solutions to deliver voice, data and video communication ser...

Lucent Technologies

Lucent Technologies designs and delivers the systems, services and software that drive next-generation communications networks. Backed by Bell Labs research and development, Lucent uses its strengths ...


Codenomicon finds security vulnerabilities others can't find. Companies rely on Codenomicon's solutions to discover zero-day vulnerabilities that cause Denial of Service (DoS) and...


Viptela is transforming enterprise networking. The company uses Software Defined Networking (SDN) technology to make Wide Area Networks (WAN) easier to manage, adaptable, secure a...

Lucent Medical Systems

Lucent Medical Systems was established in January 1994 to develop and commercialize a technology for non-radiographic determination of position, orientation and motion of devices inserted in the body...

More Information about "Alcatel-Lucent" on BioPortfolio

We have published hundreds of Alcatel-Lucent news stories on BioPortfolio along with dozens of Alcatel-Lucent Clinical Trials and PubMed Articles about Alcatel-Lucent for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alcatel-Lucent Companies in our database. You can also find out about relevant Alcatel-Lucent Drugs and Medications on this site too.

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record